Addtech (0QI7)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 329.80 |
|---|---|
| 52-week range | 280.63 – 361.38 |
| Return, 1 month / 3 months | −0.2% / +0.0% |
| Return, 1 year / 3 years | +9.8% / +96.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -14.0% |
| Average daily value traded | 28.50M SEK |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Addtech is a Swedish industrial group based in Stockholm that acquires and develops companies supplying technical products and services to industrial customers. Its businesses provide components, automation equipment, power transmission products and related technical solutions, serving manufacturers and other industrial buyers across Europe and beyond. The group operates through many separate subsidiaries, each focused on its own niche of the technical trading and manufacturing sector, while sharing common ownership and financial management.
Addtech trades under the code 0QI7 on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Addtech (0QI7) trades on the London Exchange in UK. It last closed at SEK 329.80 on 19 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 909 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.8% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.7% | ||
| From 52-week high | -7.1% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | -2.3% | ||
| 12-month return, skipping the last month | 10.0% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.0% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 28.50M SEK | ||
| Zero-volume days | 1.7% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | −0.2% |
| 3 months | +0.0% |
| 6 months | −2.3% |
| 1 year | +9.8% |
| 3 years | +96.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 333.76 / 324.38 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.48 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Aug 2026 | SEK 3.6000 |
| 28 Aug 2025 | SEK 3.2000 |
| 23 Aug 2024 | SEK 2.8000 |
| 24 Aug 2023 | SEK 2.5000 |
| 26 Aug 2022 | SEK 1.8000 |
| 27 Aug 2021 | SEK 1.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.